Tom Dubin is a pharmaceutical executive and attorney. From 2001 through 2013 he was the Chief Legal Officer and a member of the core executive team that grew Alexion Pharmaceuticals from the development stage to membership in the S&P 500. At Alexion, Tom led legal work, government affairs, pricing and reimbursement, corporate communications, and other functions, and he held commercial responsibility for the company’s Australasia region. Prior to Alexion, Tom served as Vice President, General Counsel and Secretary of ChiRex, Inc., an international corporation providing advanced process development services and specialty manufacturing to the pharmaceutical industry. Tom began his career as a corporate attorney with Cravath, Swaine & Moore in New York City. He is Vice Chair of Norwalk Hospital, past Director of BioBlast Pharmaceuticals (NASD: ORPN), member of the Advisory Board of Mythic Pharmaceuticals, and member of the Leadership Council of Yale School of Public Health. Tom holds a B.A., cum laude, from Amherst College, a J.D. from New York University School of Law, where he received the American Jurisprudence Prize in securities law, and an MPH from Yale School of Public Health.